Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ligustrazine for alcohol use disorder
ChiCTR2300072516Phase 4Not yet recruiting
- Sponsor
- Shenzhen Kangning Hospital
- Start
- Jun 2023
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Tetramethylpyrazine in alcohol use disorder (AUD) (4 arms), sponsored by Shenzhen Kangning Hospital. Primary endpoint: Relapse rate (alcohol relapse). Planned start Jun 2023; status: not yet recruiting.
02
Drugs
Tetramethylpyrazine
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on ChiCTR2300072516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072516.